XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce its participation in two upcoming virtual conferences in November 2020. The first presentation as an invited speaker is at the Meridian Clinical Trials Conference on Tuesday, November 3 rd at 2:30 pm Central time. This presentation is
October 28, 2020
· 2 min read